Konigsberg IR, Vargas LB, Pratte KA, et al. Omic Risk Scores are Associated with COPD-related Traits Across Three Cohorts. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.06.01.25328699
Publications
Atabaki NN, Coral DE, Pomares-Millan H, et al. A Biological-Systems-Based Analyses Using Proteomic and Metabolic Network Inference Reveals Mechanistic Insights into Hepatic Lipid Accumulation: An IMI-DIRECT Study. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.06.02.25328773
Cudic M, Tubbs JD, Ge T, Smoller JW. Putting Polygenic Scores in Context: How Intersectional Factors Affect Relative and Absolute Genetic Risk. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.06.04.25328987
Gunter-Rahman F, Mallett S, White F, et al. Hypoxia in extravillous trophoblasts links maternal obesity and offspring neurobehavior. iScience. 2025;28(6):112636. doi:10.1016/j.isci.2025.112636
Kaas M, Chofflet N, Bicer D, et al. Rare missense variants of the leukocyte common antigen related receptor (LAR) display reduced activity in transcellular adhesion and synapse formation. Research square. 2025. doi:10.21203/rs.3.rs-5928514/v1
Nägeli M, Rodriguez S, Iradukunda A, Manson AL, Earl AM, Brennan-Krohn T. Rapid emergence of resistance to broad-spectrum direct antimicrobial activity of avibactam. Microbiology spectrum. 2025;13(8):e0324124. doi:10.1128/spectrum.03241-24
Muir DF, Asper GPR, Notin P, et al. Evolutionary-scale enzymology enables exploration of a rugged catalytic landscape. Science (New York, N.Y.). 2025;388(6752):eadu1058. doi:10.1126/science.adu1058
Weingarten-Gabbay S, Bauer MR, Stanton AC, et al. Pan-viral ORFs discovery using massively parallel ribosome profiling. Science (New York, N.Y.). 2025;388(6752):1218-1224. doi:10.1126/science.ado6670
Gerdemann U, Kimler K, Warren MR, et al. A single dose of a CD137 antibody-drug conjugate protects rhesus macaque allogeneic HCT recipients against acute GVHD. Blood. 2025;146(9):1127-1141. doi:10.1182/blood.2024027239
Citrome L, Nagaraj N, Traverso G, Dumas T, Scranton R. Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial. The lancet. Psychiatry. 2025;12(7):504-512. doi:10.1016/S2215-0366(25)00135-X